Search research articles
Contact Us
Filters
Showing results (61-70 of 71) with videos related to
Page
of 8
Sort By:
Leukemia & Lymphoma
|
September 24, 1999
Increased serum soluble Fas ligand associated with recurrent B-cell non-Hodgkin's lymphoma after autologous peripheral blood stem cell transplantation
Y Kanda, S Chiba, Y Tanaka, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 18, 2006
Clinicopathological features of pyothorax-associated lymphoma; a retrospective survey involving 98 patients
H Narimatsu, Y Ota, M Kami, et al.
Bone Marrow Transplantation
|
February 3, 2004
Feasibility of reduced intensity hematopoietic stem cell transplantation from an HLA-matched unrelated donor
E Kusumi, M Kami, K Yuji, et al.
Bone Marrow Transplantation
|
November 13, 2001
Long-term low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation
Y Kanda, S Mineishi, T Saito, et al.
Bone Marrow Transplantation
|
November 20, 2003
Late hemorrhagic cystitis after reduced-intensity hematopoietic stem cell transplantation (RIST)
R Yamamoto, E Kusumi, M Kami, et al.
Bone Marrow Transplantation
|
July 3, 2003
High complete response rate after allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning regimens in advanced malignant lymphoma
T E Tanimoto, E Kusumi, T Hamaki, et al.
Bone Marrow Transplantation
|
March 10, 2005
Reduced-intensity stem-cell transplantation for adult acute lymphoblastic leukemia: a retrospective study of 33 patients
T Hamaki, M Kami, Y Kanda, et al.
Bone Marrow Transplantation
|
April 21, 2001
Pre-emptive therapy against cytomegalovirus (CMV) disease guided by CMV antigenemia assay after allogeneic hematopoietic stem cell transplantation: a single-center experience in Japan
Y Kanda, S Mineishi, T Saito, et al.
Bone Marrow Transplantation
|
August 23, 2005
Comparison between reduced intensity and conventional myeloablative allogeneic stem-cell transplantation in patients with hematologic malignancies aged between 50 and 59 years
R Kojima, M Kami, Y Kanda, et al.
Bone Marrow Transplantation
|
April 20, 2004
A nationwide survey of deep fungal infections and fungal prophylaxis after hematopoietic stem cell transplantation in Japan
O Imataki, M Kami, S-W Kim, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 71) with videos related to
Sort By:
Page
of 8
Leukemia & Lymphoma
|
September 24, 1999
Increased serum soluble Fas ligand associated with recurrent B-cell non-Hodgkin's lymphoma after autologous peripheral blood stem cell transplantation
Y Kanda, S Chiba, Y Tanaka, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 18, 2006
Clinicopathological features of pyothorax-associated lymphoma; a retrospective survey involving 98 patients
H Narimatsu, Y Ota, M Kami, et al.
Bone Marrow Transplantation
|
February 3, 2004
Feasibility of reduced intensity hematopoietic stem cell transplantation from an HLA-matched unrelated donor
E Kusumi, M Kami, K Yuji, et al.
Bone Marrow Transplantation
|
November 13, 2001
Long-term low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation
Y Kanda, S Mineishi, T Saito, et al.
Bone Marrow Transplantation
|
November 20, 2003
Late hemorrhagic cystitis after reduced-intensity hematopoietic stem cell transplantation (RIST)
R Yamamoto, E Kusumi, M Kami, et al.
Bone Marrow Transplantation
|
July 3, 2003
High complete response rate after allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning regimens in advanced malignant lymphoma
T E Tanimoto, E Kusumi, T Hamaki, et al.
Bone Marrow Transplantation
|
March 10, 2005
Reduced-intensity stem-cell transplantation for adult acute lymphoblastic leukemia: a retrospective study of 33 patients
T Hamaki, M Kami, Y Kanda, et al.
Bone Marrow Transplantation
|
April 21, 2001
Pre-emptive therapy against cytomegalovirus (CMV) disease guided by CMV antigenemia assay after allogeneic hematopoietic stem cell transplantation: a single-center experience in Japan
Y Kanda, S Mineishi, T Saito, et al.
Bone Marrow Transplantation
|
August 23, 2005
Comparison between reduced intensity and conventional myeloablative allogeneic stem-cell transplantation in patients with hematologic malignancies aged between 50 and 59 years
R Kojima, M Kami, Y Kanda, et al.
Bone Marrow Transplantation
|
April 20, 2004
A nationwide survey of deep fungal infections and fungal prophylaxis after hematopoietic stem cell transplantation in Japan
O Imataki, M Kami, S-W Kim, et al.
Page
of 8